Guerbet SA

4G8-FF:Frankfurt Stock Exchange
RT Quote | Exchange | EUR
Last | 01/22/21 CET
35.05quote price arrow down-0.85 (-2.37%)
52 week range
25.15 - 37.95

...

Loading . . .

KEY STATS

  • Open35.05
  • Day High35.05
  • Day Low35.05
  • Prev Close35.90
  • 52 Week High37.95
  • 52 Week High Date01/21/20
  • 52 Week Low25.15
  • 52 Week Low Date09/29/20
  • Market Cap535.59M
  • Shares Out12.58M
  • 10 Day Average Volume15.42
  • Dividend0.70
  • Dividend Yield2.00%
  • Beta
  • 1 Year % Change-6.66

RATIOS/PROFITABILITY

  • EPS (TTM)2.11
  • P/E (TTM)16.61
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date06/30/2020
  • Div Amount0.70
  • Split Date-
  • Split Factor-

Latest Guerbet SA News

There is no recent news for this security.

Latest 4G8-FF News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Guerbet SA is a France-based pharmaceutical group specialized in the manufacture and marketing of medical imaging contrast agents destined for diagnostic purposes. It produces medical imaging contrast products for x-ray imaging, magnetic resonance imaging (MRI), ultrasound imaging and for nuclear medicine. The contrast agents are used in the diagnosis of cardio-vascular, inflammatory and neuro-degenerative disorders. The Company’s portfolio of products comprises brands, such...
Marie-Claire Janailhac-Fritsch
Chairman
David Hale
Chief Executive Officer
Jerome Estampes
Chief Financial Officer
Petra Zalabak
Vice President
Philippe Bourrinet
Vice President
Address
15 rue des Vanesses, Zone Paris Nord II
Villepinte
93420
France